Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group
Bruno Dubois, Nicolas Villain, Giovanni B. Frisoni, et al.
The Lancet Neurology (2021) Vol. 20, Iss. 6, pp. 484-496
Open Access | Times Cited: 690

Showing 1-25 of 690 citing articles:

Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup
Clifford R. Jack, J. Scott Andrews, Thomas G. Beach, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 8, pp. 5143-5169
Open Access | Times Cited: 496
The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease
Oskar Hansson, Rebecca M. Edelmayer, Adam L. Boxer, et al.
Alzheimer s & Dementia (2022) Vol. 18, Iss. 12, pp. 2669-2686
Open Access | Times Cited: 362
Alzheimer’s Disease: Epidemiology and Clinical Progression
Amir Abbas Tahami Monfared, Michael Byrnes, Leigh Ann White, et al.
Neurology and Therapy (2022) Vol. 11, Iss. 2, pp. 553-569
Open Access | Times Cited: 307
Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline
Rik Ossenkoppele, Alexa Pichet Binette, Colin Groot, et al.
Nature Medicine (2022) Vol. 28, Iss. 11, pp. 2381-2387
Open Access | Times Cited: 261
Blood phospho-tau in Alzheimer disease: analysis, interpretation, and clinical utility
Thomas K. Karikari, Nicholas J. Ashton, Gunnar Brinkmalm, et al.
Nature Reviews Neurology (2022) Vol. 18, Iss. 7, pp. 400-418
Closed Access | Times Cited: 211
The human connectome in Alzheimer disease — relationship to biomarkers and genetics
Meichen Yu, Olaf Sporns, Andrew J. Saykin
Nature Reviews Neurology (2021) Vol. 17, Iss. 9, pp. 545-563
Open Access | Times Cited: 176
Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum
Willemijn J. Jansen, Olin Janssen, Betty M. Tijms, et al.
JAMA Neurology (2022) Vol. 79, Iss. 3, pp. 228-228
Open Access | Times Cited: 163
Microglia and monocytes in inflammatory CNS disease: integrating phenotype and function
Alanna G. Spiteri, Claire L. Wishart, Roger Pamphlett, et al.
Acta Neuropathologica (2021) Vol. 143, Iss. 2, pp. 179-224
Open Access | Times Cited: 148
Brain-derived tau: a novel blood-based biomarker for Alzheimer’s disease-type neurodegeneration
Fernándo González‐Ortiz, Michael Turton, Przemysław R. Kac, et al.
Brain (2022) Vol. 146, Iss. 3, pp. 1152-1165
Open Access | Times Cited: 140
PM2.5 exposure in association with AD-related neuropathology and cognitive outcomes
Kitti Thiankhaw, Nipon Chattipakorn, Siriporn C. Chattipakorn
Environmental Pollution (2021) Vol. 292, pp. 118320-118320
Closed Access | Times Cited: 122
PET Imaging of Neuroinflammation in Alzheimer’s Disease
Rong Zhou, Bin Ji, Yanyan Kong, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 119
CSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer’s disease
Kanta Horie, Gemma Salvadó, Nicolas R. Barthélemy, et al.
Nature Medicine (2023) Vol. 29, Iss. 8, pp. 1954-1963
Open Access | Times Cited: 118
Dementia prevention in memory clinics: recommendations from the European task force for brain health services
Giovanni B. Frisoni, Daniele Altomare, Federica Ribaldi, et al.
The Lancet Regional Health - Europe (2023) Vol. 26, pp. 100576-100576
Open Access | Times Cited: 116
The amyloid cascade hypothesis: an updated critical review
Kasper P. Kepp, Nikolaos K. Robakis, Poul Flemming Høilund‐Carlsen, et al.
Brain (2023) Vol. 146, Iss. 10, pp. 3969-3990
Open Access | Times Cited: 114
Quantification of amyloid PET for future clinical use: a state-of-the-art review
Hugh Pemberton, Lyduine E. Collij, Fiona Heeman, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2022) Vol. 49, Iss. 10, pp. 3508-3528
Open Access | Times Cited: 109
The Role of Amyloid PET in Imaging Neurodegenerative Disorders: A Review
Marianne Chapleau, Leonardo Iaccarino, David N. Soleimani‐Meigooni, et al.
Journal of Nuclear Medicine (2022) Vol. 63, Iss. Supplement 1, pp. 13S-19S
Open Access | Times Cited: 107
Designing the next-generation clinical care pathway for Alzheimer’s disease
Harald Hampel, Rhoda Au, Soeren Mattke, et al.
Nature Aging (2022) Vol. 2, Iss. 8, pp. 692-703
Open Access | Times Cited: 107
Plasma proteomic profiles predict future dementia in healthy adults
Yu Guo, Jia You, Yi Zhang, et al.
Nature Aging (2024) Vol. 4, Iss. 2, pp. 247-260
Closed Access | Times Cited: 107
Current Understanding of Hydrogel for Drug Release and Tissue Engineering
Lanjie Lei, Yujing Bai, Xinyun Qin, et al.
Gels (2022) Vol. 8, Iss. 5, pp. 301-301
Open Access | Times Cited: 98
An accurate fully automated panel of plasma biomarkers for Alzheimer's disease
Sebastian Palmqvist, Erik Stomrud, Nicholas Cullen, et al.
Alzheimer s & Dementia (2022) Vol. 19, Iss. 4, pp. 1204-1215
Open Access | Times Cited: 96
The Humanistic and Economic Burden of Alzheimer's Disease
Amir Abbas Tahami Monfared, Michael Byrnes, Leigh Ann White, et al.
Neurology and Therapy (2022) Vol. 11, Iss. 2, pp. 525-551
Open Access | Times Cited: 92
Biomarkers in Alzheimer’s disease: role in early and differential diagnosis and recognition of atypical variants
Bruno Dubois, Christine A. F. Von Arnim, Nerida Burnie, et al.
Alzheimer s Research & Therapy (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 85
Blood Biomarkers to Detect Alzheimer Disease in Primary Care and Secondary Care
Sebastian Palmqvist, Pontus Tideman, Niklas Mattsson, et al.
JAMA (2024) Vol. 332, Iss. 15, pp. 1245-1245
Closed Access | Times Cited: 85
Molecular Mechanisms of Neuroinflammation in Aging and Alzheimer’s Disease Progression
Felicia Liana Andronie-Cioară, Adriana Ioana Ardelean, Carmen Delia Nistor-Cseppento, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 1869-1869
Open Access | Times Cited: 84
The Role of Glymphatic System in Alzheimer’s and Parkinson’s Disease Pathogenesis
Francesca R. Buccellato, Marianna D’Anca, María Serpente, et al.
Biomedicines (2022) Vol. 10, Iss. 9, pp. 2261-2261
Open Access | Times Cited: 78
Page 1 - Next Page

Scroll to top